MedPath

GlobalSurg-CovidSurg Week

Conditions
Surgery
Covid19
Post-Op Complication
Registration Number
NCT04509986
Lead Sponsor
University of Birmingham
Brief Summary

Observational study to determine the optimal timing for surgery following SARS-CoV-2 infection and assess key global surgery indicators.

Detailed Description

* Prospective, observational international cohort study.

* Any hospital worldwide can participate (including hospitals that have not admitted SARS-CoV-2 infected patients).

* All patients undergoing a surgical procedure in an operating theatre will be included. All consecutive eligible patients should be included.

* 7-day data collection period, with follow-up at 30 days after surgery for each patient. However, no changes should be made to normal patient care/ follow-up pathways

* Primary outcome is 30-day mortality.

* All collaborators will be included as PubMed-citable co-authors on resulting publications.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-operative mortality30 days after surgery

Mortality at 30 days after surgery

Secondary Outcome Measures
NameTimeMethod
In-patient mortality30 days after surgery

Mortality while the patient is admitted to hospital

Post-operative complications30 days after surgery

30-day Clavien-Dindo grade

Post-operative pulmonary complications30 days after surgery

30-day postoperative pulmonary complications (pneumonia \[CDC definition\], ARDS, unexpected ventilation)

Post-operative venous thromboembolism30 days after surgery

30-day venous thromboembolism (deep vein thrombosis/ pulmonary embolism)

© Copyright 2025. All Rights Reserved by MedPath